アルテスナートに結合したヘプタメチンカルボシアニンDZ-1の抗がん性における現在の進歩:反応性酸素種の生成
Badrinath Narayanasamy1, Sarah Helmueller1, Yi Zhang1
1Department of Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California, USA.
Journal of cellular biochemistry
|September 2, 2025
まとめ
新型DZ- 1ARTコンジュガートは,アポトーシスを誘発することによって強力な抗がん作用を示しています. このプロセスは,ミトコンドリアの機能障害と,バックとバックスタンパク質から独立して活性酸素種を生成する.
科学分野:
- 薬剤化学
- 分子生物学
- 癌 研究
背景:
- ヘプタメチンシアニン染料と抗がん剤の結合物は 標的型がん治療法として登場しています
- 以前の研究では,DZ-1染料の結合体の細胞毒性と作用機構が確認された.
- アルテスナートは,抗マラリア薬で,抗がん性があることが知られている.
研究 の 目的:
- 様々な癌細胞系における新しいDZ-1とアルテスナート結合体 (DZ-1-ART) の細胞毒性を評価する.
- DZ-1-ART誘発の癌細胞死の原因となる特定のメカニズムを解明する.
主な方法:
- HCT116,BxPC-3,OVCAR-3の細胞系で細胞活性アッセイ (MTTなど) を実施した.
- アポトーシスは,免疫ボルトリングと末端デオキシヌクレオチドリルトランスファーゼ (dUTP) ニックエンドラベル (TUNEL) アッセイを用いて確認された.
- ミトコンドリア機能は,MitoTrackerとJC-1アッセイを用いて評価され,反応性酸素種 (ROS) の生成は,二塩素フッ素アセテートアッセイを用いて測定された.
主要な成果:
- DZ- 1ARTは,検査されたがん細胞系において,用量依存の細胞毒性を示した.
- アポトーシスは,DZ - 1 - ART誘発の細胞死の主なメカニズムとして特定されました.
- DZ- 1ART治療はミトコンドリア外膜の潜在障害と重要なROS生成を引き起こし,これはN- アセチルシステインによって逆転した.
結論:
- DZ- 1ARTは癌細胞におけるアポトーシスを効果的に誘発する.
- 抗癌メカニズムはミトコンドリア媒介経路とROS生成を伴う.
- DZ-1-ARTによって誘発されるアポトーシスは,BakとBaxタンパク質とは独立しています.
さらに関連する動画
05:16Author Spotlight: High-Throughput Measurement of Intracellular ROS Levels in Hepatocellular Lines
Published on: January 19, 2024
5.1K
09:33Formation of Covalent DNA Adducts by Enzymatically Activated Carcinogens and Drugs In Vitro and Their Determination by 32P-postlabeling
Published on: March 20, 2018
13.9K
関連する概念動画
Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
Electron Transport Chain: Complex I and II
15.0K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
15.0K
Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.1K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
3.1K
